The Role of an Intermediate Conformation of SHP2 in the MEK Pathway of KRAS-Driven Cancers

被引：0
|
作者：
Shannon, Daniel [1 ]
Poetker, Gavin [1 ]
Kaplan, Donnie [1 ]
Gruber, Weston [1 ]
Pease, Emmet [1 ]
McCloud, Brandon [1 ]
Allen, Jake [1 ]
Connolly, Connor [1 ]
Diao, JiaJie [1 ]
机构：
[1] Archbishop Moeller High Sch, Cincinnati, OH USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
关键词：
D O I：
10.1016/j.jbc.2024.107183
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2339
引用
收藏
页码：S791 / S791
页数：1
相关论文
共 50 条
  • [1] Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
    Dietrich A. Ruess
    Guus J. Heynen
    Katrin J. Ciecielski
    Jiaoyu Ai
    Alexandra Berninger
    Derya Kabacaoglu
    Kivanc Görgülü
    Zahra Dantes
    Sonja M. Wörmann
    Kalliope N. Diakopoulos
    Angeliki F. Karpathaki
    Marlena Kowalska
    Ezgi Kaya-Aksoy
    Liang Song
    Eveline A. Zeeuw van der Laan
    María P. López-Alberca
    Marc Nazaré
    Maximilian Reichert
    Dieter Saur
    Mert M. Erkan
    Ulrich T. Hopt
    Bruno Sainz
    Walter Birchmeier
    Roland M. Schmid
    Marina Lesina
    Hana Algül
    Nature Medicine, 2018, 24 : 954 - 960
  • [2] Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
    Ruess, Dietrich A.
    Heynen, Guus J.
    Ciecielski, Katrin J.
    Ai, Jiaoyu
    Berninger, Alexandra
    Kabacaoglu, Derya
    Goerguelue, Kivanc
    Dantes, Zahra
    Woermann, Sonja M.
    Diakopoulos, Kalliope N.
    Karpathaki, Angeliki F.
    Kowalska, Marlena
    Kaya-Aksoy, Ezgi
    Song, Liang
    van der Laan, Eveline A. Zeeuw
    Lopez-Alberca, Maria P.
    Nazare, Marc
    Reichert, Maximilian
    Saur, Dieter
    Erkan, Mert M.
    Hopt, Ulrich T.
    Sainz, Bruno, Jr.
    Birchmeier, Walter
    Schmid, Roland M.
    Lesina, Marina
    Alguel, Hana
    NATURE MEDICINE, 2018, 24 (07) : 954 - +
  • [3] An essential role for Argonaute 2 in mouse models of KRAS-driven cancers
    Shankar, Sunita
    Tien, Jean Ching-Yi
    Siebenaler, Ronald F.
    Dommeti, Vijaya L.
    Zelenka-Wang, Sylvia
    Waninger, Jessica
    Juckette, Kristin M.
    Xu, Alice
    Wang, Xiao-Ming
    Chugh, Seema
    Mody, Malay
    Eyunni, Sanjana
    Goodrum, Andrew
    Tsaloff, Grace
    Zhang, Yuping
    Apel, Ingrid J.
    Siddiqui, Javed
    Smith, Richard D.
    Carlson, Heather A.
    Tesmer, John
    Cao, Xuhong
    Shi, Jiaqi
    Kumar-Sinha, Chandan
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] A critical role of the SUMO pathway in KRAS-driven oncogenesis
    Yu, Bing
    Swatkoski, Steve
    Holly, Alesia
    Lee, Liam Changwoo
    Giroux, Valentin
    Lee, Chih-Shia
    Carver, Joseph
    Creighton, Chad
    Ann, David K.
    Figg, William Douglas
    Gucek, Marjan
    Luo, Ji
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [5] Cancer vaccines: Targeting KRAS-driven cancers
    Zhang, Ying
    Ma, Jin-An
    Zhang, Hai-Xia
    Jiang, Yu-Na
    Luo, Wen-Hao
    EXPERT REVIEW OF VACCINES, 2020, 19 (02) : 163 - 173
  • [6] Developing combinatorial therapies for KRAS-driven cancers
    Cichowski, Karen
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [7] The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers
    Mokhlis, Hamada A.
    Bayraktar, Recep
    Kabil, Nashwa N.
    Caner, Ayse
    Kahraman, Nermin
    Rodriguez-Aguayo, Cristian
    Zambalde, Erika P.
    Sheng, Jianting
    Karagoz, Kubra
    Kanlikilicer, Pinar
    Aziz, Abdel Aziz H. Abdel
    Abdelghany, Tamer M.
    Ashour, Ahmed A.
    Wong, Stephen
    Gatza, Michael L.
    Calin, George A.
    Lopez-Berestein, Gabriel
    Ozpolat, Bulent
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 14 : 301 - 317
  • [8] SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS mutant tumors treated with MEK inhibitors
    Lu, Hengyu
    Liu, Chen
    Velazquez, Roberto
    Wang, Hongyun
    Dunkl, Lukas M.
    Kazic-Legueux, Malika
    Haberkorn, Anne
    Billy, Eric
    Manchado, Eusebio
    Brachmann, Saskia M.
    Moody, Susan
    Engelman, Jeffrey A.
    Hammerman, Peter S.
    Caponigro, Giordano
    Mohseni, Morvarid
    Hao, Huaixiang
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Targeting metabolic reprogramming in KRAS-driven cancers
    Kenji Kawada
    Kosuke Toda
    Yoshiharu Sakai
    International Journal of Clinical Oncology, 2017, 22 : 651 - 659
  • [10] A synergistic combination therapy for KRAS-driven cancers
    Yang, Z.
    Liang, S-Q.
    Peng, R-W.
    Schmid, R. A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S706 - S706
12345